Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review.

Almomani E, Dukuray M, Putten IV, Paulus A, Al-Lahham A, van Mastrigt GAPG

Open source

DOI
10.1017/s0266462326103912
Published
2026 Jul 17
Container
International journal of technology assessment in health care
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/s0266462326103912,
  title = {Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review.},
  author = {Almomani E and Dukuray M and Putten IV and Paulus A and Al-Lahham A and van Mastrigt GAPG},
  year = {2026},
  journal = {International journal of technology assessment in health care},
  doi = {10.1017/s0266462326103912},
  url = {https://doi.org/10.1017/s0266462326103912}
}

RIS

TY  - JOUR
TI  - Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review.
AU  - Almomani E
AU  - Dukuray M
AU  - Putten IV
AU  - Paulus A
AU  - Al-Lahham A
AU  - van Mastrigt GAPG
PY  - 2026
JO  - International journal of technology assessment in health care
DO  - 10.1017/s0266462326103912
UR  - https://doi.org/10.1017/s0266462326103912
ER  - 

APA

E, A., M, D., IV, P., A, P., A, A., & GAPG, V. M. (2026). Consideration of intersectoral costs and benefits in health economic evaluations of pneumococcal conjugate vaccines: a systematic review.. International journal of technology assessment in health care. https://doi.org/10.1017/s0266462326103912

Source records